Experiment: 6I4O

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	1.3 mM ZP-DNA	100% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600
2	2D DQF-COSY	1.3 mM ZP-DNA	100% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600
3	2D 1H-1H TOCSY	1.3 mM ZP-DNA	100% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600
4	2D 1H-13C HSQC	1.3 mM ZP-DNA	100% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600
5	2D 1H-1H NOESY	1.3 mM ZP-DNA	90% H2O/10% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600
6	2D 31P-1H COSY	1.3 mM ZP-DNA	100% D2O	100 mM	7.5	1 atm	298	Bruker AVANCE II 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	600

NMR Refinement
Method	Details	Software
simulated annealing		Amber
molecular dynamics		Amber

NMR Ensemble Information
Conformer Selection Criteria	clustering of MD
Conformers Calculated Total Number	5000
Conformers Submitted Total Number	10
Representative Model	1 (most represented cluster)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	Sparky		Goddard
2	processing	TopSpin		Bruker
4	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
5	refinement	MARDIGRAS		Brandan A. Borgias Paul D. Thomas He Liu Anil Kumar
6	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.